{"id": "1359264531545997316", "creation": 1612908892.0, "user_id": "1321134820894846976", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 1, "like_count": 2, "quote_count": 0}}, "text": "Vaxart, Inc., #NASDAQ: $VXRT released data from its Phase 1 trial of VXA-CoV2-1, its oral #COVID19 tablet #vaccine candidate. Neutralizing antibodies were not detected in serum and Immunoglobulin G (IgG) responses, a type of antibody, were also not detected in most subjects.", "first_save": 1634559108.199414, "hashtags": ["#NASDAQ", "#COVID19", "#VACCINE"]}